Early-life infection burden is associated with an increased risk for later moderate-to-severe infections and systemic ...

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, ...

This longitudinal cohort study suggests that early-life infection burden may continue throughout childhood and is associated with later antibiotic treatments independent of social and environmental ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

China faces a surge in respiratory infections, likely linked to Human Metapneumovirus (HMPV), causing overcrowded hospitals.

The recent surge in Human Metapneumovirus (HMPV) cases in China has triggered global attention, prompting the Indian health ...

A new test can differentiate between various types of asthma via a nasal swab. Researchers hope it can eventually help match ...

A NEW nasal swab has been found to diagnose asthma in children far quicker than previous methods. The test, developed by American researchers, is able to diagnose specific subtypes of asthma.

INR:8447. icc live match video Sanofi's Dupixent is a successful Phase III study in the treatment of moderate to severe asthma in children Kangmei Pharmaceut ...

Xolair (omalizumab) is a prescription drug used to treat certain conditions, such as asthma or food allergies. The drug comes as an injection. It’s usually given once every 2 or 4 weeks.